Antimicrobial copper-alloy touch surfaces follows: The following claims are now legally permitted when marketing EPA-registered antimicrobial copper alloys in the U.S.: The registrations state that “antimicrobial copper alloys may be used in hospitals, other healthcare facilities, and various public, commercial and residential buildings.” The EPA copper alloy registrations were granted “with public health claims,” meaning that they permit manufacturers of copper-based products sold in the U.S. to claim on their labels the ability of copper, brass, and bronze to kill harmful, potentially deadly bacteria. As a condition of registration established by EPA, the Copper Development Association (CDA) in the U.S. is responsible for the
Tin(II) chloride to maintain the equilibrium towards the left-hand side (using Le Chatelier's principle). Solutions of SnCl are also unstable towards oxidation by the air: This can be prevented by storing the solution over lumps of tin metal. There are many such cases where tin(II) chloride acts as a reducing agent, reducing silver and gold salts to the metal, and iron(III) salts to iron(II), for example: It also reduces copper(II) to copper(I). Solutions of tin(II) chloride can also serve simply as a source of Sn ions, which can form other tin(II) compounds via precipitation reactions. For example, reaction with sodium sulfide produces